ASC growth to outpace HOPDs in the global micro-invasive glaucoma surgery market: 3 insights

Through 2022, the global micro-invasive glaucoma surgery market is likely to increase at a 47.1 percent compound annual growth rate.

Here are three insights:

1. Based on end-users, ASCs are likely to have more growth than hospital outpatient departments in the market.

2. Factors driving market growth include a higher number of glaucoma patients, a growing aging population, new devices surfacing in the market, more awareness on safety and less use of prescription eye drops.

3. Asia Pacific will likely increase at the highest CAGR due to a large glaucoma population and more residents using these devices.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast